Drug Trial Radar · NCT06651541
Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
Last checked: Nov 19, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
174
Planned (sponsor's estimate)
Start
Jul 1, 2026
Primary completion
Jun 30, 2027
Study completion Jul 31, 2027
Sponsor
- Lead sponsor
- Biozeus Biopharmaceutical S.A.Industry
- Sponsor type
- Industry
- First posted
- Oct 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 21 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluation of the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder
Conditions
- Female Sexual Arousal Disorder
- Female Sexual Dysfunction (FSD)
Interventions
BZ371A (0.5 ml)Drug
Formulation with the active ingredient
Placebo (0.5 ml)Drug
Formulation without the active ingredient
Placebo (1.0 ml)Drug
Formulation without the active ingredient
BZ371A (1.0 ml)Drug
Formulation with the active ingredient
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy in increasing arousalTime frame: Baseline, 4 weeks and 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ambulatório Jenny Farias do Hospital das Clínicas da UFMG
Belo Horizonte, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.